More Information »Glycosylases are a group of enzymes that includes glucosidases, mannosidases and heparanases. There are two glucosidase subtypes, both found in the gut. They hydrolyze terminal (1,4)α-glucosidic linkages and (1,6)β-glucosidic linkages, liberating α-glucose and β-glucose.
Product Name / Activity
|Glucosidase α inhibitor (intestinal)|
|Glucosidases α and β inhibitor|
|α-Mannosidase I inhibitor|
|Glucosidase I and II inhibitor|
|Inhibitor of class I α-mannosidases|
|α-glucosidase I and II inhibitor. Also inhibits ceramide-specific glycosyltransferases|
|Heparanase inhibitor. Antiangiogenic|
|Inhibitor of α-mannosidase II|
|Orally active α-glucosidase inhibitor|
Find multiple products by catalog number
Potent, selective LRRK2 inhibitor
Tocris is the first to launch GSK2578215A, licensed from GlaxoSmithKline, for the study of Parkinson's Disease.